Mediso Medical Imaging Systems

Budapest, Hungary

Mediso Medical Imaging Systems

Budapest, Hungary
SEARCH FILTERS
Time filter
Source Type

— Global Nuclear Medicine Equipment Market,By Product (Single-Photon Emission Computed Tomography (SPECT) (Standalone, Hybrid), Planar Scintigraphy, Hybrid Pet), by Application (Oncology, Cardiology, Neurology), by End-user (Hospitals, Imaging Centers, Academic & Research Centers), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024 Nuclear Medicine Equipment are the equipments used to examine different processes including metabolism, tissue blood flow, expression of cell receptors in normal and abnormal cells, neurotransmitter activity, homing, cell trafficking, and apoptosis. Major Market Drivers and Restraints:  Increasing incidences and prevalence of diseases such as cancer  Technological advancements in medical imaging devices  Government initiatives in modernizing diagnostic imaging centers  High cost of nuclear imaging equipment  Shorter half-life of radiopharmaceuticals By product, the market for nuclear medicine equipment market is segmented into single-photon emission computed tomography (SPECT), planar scintigraphy, hybrid pet. The single-photon emission computed tomography (SPECT) segment is further sub-segmented into standalone, and hybrid. By application, the market for nuclear medicine equipment market is segmented into oncology, cardiology, neurology, and others. On the basis of end-user, the nuclear medicine equipment market is segmented into hospitals, imaging centers, academic & research centers. Based on geography, the market is segmented into five geographical regions: • North America • South America • Europe • Asia-Pacific(APAC) • Middle East and Africa(MEA) Global Nuclear Medicine Equipment is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market Some of the major players operating in this market are • Philips Healthcare • GE Healthcare • Cardinal Health Inc • Siemens AG • Digirad Corporation • Mediso Medical Imaging Systems, Ltd • Toshiba Medical Systems Corporation • DDD-Diagnostics A/S • Neusoft Medical Systems Co. Ltd • Mallinckrodt plc, SurgicEye GmbH • CMR Naviscan Corporation (U.S.), Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry. Related Report Europe Electrophysiology Market – Trends and Forecast to 2024 By Type (EP Monitoring Devices, EP Treatment Devices), By Product Type(EP Ablation Catheters, EP Diagnostic Catheters, EP Laboratory Devices, Access Devices), By Indication(Atrial Fibrillation, Atrial Flutter, Ventricular Fibrillation, Ventricular Tachycardia, Atrial Tachycardia, Wolff-Parkinson-White (WPW) Syndrome And Atrioventricular Nodal Reentry Tachycardia), By Country (Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzeland, Rest Of Europe) – Industry Trends and Forecast to 2024. http://databridgemarketresearch.com/reports/europe-electrophysiology-market/ About Data Bridge Market Research: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. For more information, please visit http://databridgemarketresearch.com/reports/global-nuclear-medicine-equipment-market/


News Article | November 18, 2016
Site: marketersmedia.com

— Publishers market research analyst predicts that the global market for medical imaging will grow at a CAGR of nearly 5% by 2020. The growing focus on R&D to provide high-quality imaging for better diagnosis and treatment of diseases is a critical factor that drives the global demand for medical imaging devices during the forecast period. In this market research, analysts have estimated eminent factors, such as the advent of 4D medical imaging technology, to spur market growth during the forecast period. Since 4D imaging technology enables doctors to create a 3D picture in real time, its augmented application in ultrasound systems will foster the prospects for growth in this market during the predicted period. MRI CT Scanners General X-rays SPECT/PET Ultrasound The general X-ray imaging segment currently dominates the market and is anticipated to grow at a modest CAGR of more than 3% by 2020. Factors such as increased regulatory approvals of imaging systems, the advent of improved and rapid imaging technologies, and the growing focus on early diagnosis and treatment will lead to growth in this market segment during the forecast period. Geographical segmentation and analysis of the medical imaging market Americas APAC EMEA Publisher market research analysts estimate the medical imaging market in APAC to grow at a CAGR of more than 8% by 2020. The introduction of government initiatives that focuses on the improvement of healthcare infrastructure in developing economies is a significant factor that results in this region€™s impressive market growth rate during the forecast period. The global market for medical imaging is highly competitive due to the presence of many multinational companies that consistently focus on R&D to bring about product innovations. The major players in this market are focusing on value segments and advanced products that can provide high-quality imaging at a faster diagnosis time. This growing focus on value segments will help vendors to bolster product sales during the forecast period. Leading vendors in the market are - Siemens GE Philips Toshiba Carestream Other prominent vendors in the market include Hitachi Medical Corporation, Hologic, Esaote, Fujifilm Holdings, Sectra, Atlantis Worldwide, Imaging equipment, TeraRecon, Varian Medical Systems, Lupica Medical Systems, Fisher Medical Technologies, Medical imaging IMCO Inc., OREX Computed Radiography, Swissray, Mindray Medical International, Planmeca, Brain Biosciences, CMR Naviscan, Mediso Medical Imaging Systems, NIPK Electron, Analogic Corporation, Sonosite, Samsung Medison, TomTec, BK Medical, Zonare Medical Systems Get Sample of the Report at: http://www.reportsweb.com/inquiry&RW0001202295/sample . Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Market landscape PART 06: Market segmentation by technique PART 07: Geographical segmentation PART 08: Market drivers PART 09: Market challenges PART 10: Impact of drivers and challenges PART 11: Market trends PART 12: Vendor landscape PART 13: Key vendor analysis PART 14: Appendix PART 15: Explore Publisher For more information, please visit http://www.reportsweb.com/global-medical-imaging-market-2016-2020


— Publisher’s market research analyst predicts that the global market for medical imaging will grow at a CAGR of nearly 5% by 2020. The growing focus on R&D to provide high-quality imaging for better diagnosis and treatment of diseases is a critical factor that drives the global demand for medical imaging devices during the forecast period. In this market research, analysts have estimated eminent factors, such as the advent of 4D medical imaging technology, to spur market growth during the forecast period. Since 4D imaging technology enables doctors to create a 3D picture in real time, its augmented application in ultrasound systems will foster the prospects for growth in this market during the predicted period. MRI CT Scanners General X-rays SPECT/PET Ultrasound The general X-ray imaging segment currently dominates the market and is anticipated to grow at a modest CAGR of more than 3% by 2020. Factors such as increased regulatory approvals of imaging systems, the advent of improved and rapid imaging technologies, and the growing focus on early diagnosis and treatment will lead to growth in this market segment during the forecast period. Geographical segmentation and analysis of the medical imaging market Americas APAC EMEA Publisher market research analysts estimate the medical imaging market in APAC to grow at a CAGR of more than 8% by 2020. The introduction of government initiatives that focuses on the improvement of healthcare infrastructure in developing economies is a significant factor that results in this region€™s impressive market growth rate during the forecast period. Get Sample of the Report at: http://www.reportsweb.com/inquiry&RW0001202295/sample . The global market for medical imaging is highly competitive due to the presence of many multinational companies that consistently focus on R&D to bring about product innovations. The major players in this market are focusing on value segments and advanced products that can provide high-quality imaging at a faster diagnosis time. This growing focus on value segments will help vendors to bolster product sales during the forecast period. Leading vendors in the market are - Siemens GE Philips Toshiba Carestream Other prominent vendors in the market include Hitachi Medical Corporation, Hologic, Esaote, Fujifilm Holdings, Sectra, Atlantis Worldwide, Imaging equipment, TeraRecon, Varian Medical Systems, Lupica Medical Systems, Fisher Medical Technologies, Medical imaging IMCO Inc., OREX Computed Radiography, Swissray, Mindray Medical International, Planmeca, Brain Biosciences, CMR Naviscan, Mediso Medical Imaging Systems, NIPK Electron, Analogic Corporation, Sonosite, Samsung Medison, TomTec, BK Medical, Zonare Medical Systems Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Market landscape PART 06: Market segmentation by technique PART 07: Geographical segmentation PART 08: Market drivers PART 09: Market challenges PART 10: Impact of drivers and challenges PART 11: Market trends PART 12: Vendor landscape PART 13: Key vendor analysis PART 14: Appendix PART 15: Explore Publisher For more information, please visit http://www.reportsweb.com/global-medical-imaging-market-2016-2020


This report studies sales (consumption) of Small Animal Imaging Reagents in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Bruker Corporation (U.S.) Siemens AG (Germany) Life Technologies Corporation (U.S.) FUJIFILM Holdings Corporation (Japan) Miltenyi Biotec GmbH (Germany) PerkinElmer, Inc. (U.S.) Bioscan, Inc. (U.S.) Mediso Medical Imaging Systems (Hungary) Gamma Medica (U.S.) Aspect Imaging (Israel) View Full Report With Complete TOC, List Of Figure and Table: http://globalqyresearch.com/europe-small-animal-imaging-reagents-market-report-2016 Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Small Animal Imaging Reagents in these countries, from 2011 to 2021 (forecast), like Germany France UK Russia Italy Spain Benelux Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into Mri contrasting reagents Ct contrast reagents Ultrasound contrast reagents Nuclear and optical imaging agents Split by application, this report focuses on sales, market share and growth rate of Small Animal Imaging Reagents in each application, can be divided into Pharma companies Research institutions Others Europe Small Animal Imaging Reagents Market Report 2016 1 Small Animal Imaging Reagents Overview 1.1 Product Overview and Scope of Small Animal Imaging Reagents 1.2 Classification of Small Animal Imaging Reagents 1.2.1 Mri contrasting reagents 1.2.2 Ct contrast reagents 1.2.3 Ultrasound contrast reagents 1.2.4 Nuclear and optical imaging agents 1.3 Application of Small Animal Imaging Reagents 1.3.1 Pharma companies 1.3.2 Research institutions 1.3.3 Others 1.4 Small Animal Imaging Reagents Market by Countries 1.4.1 Germany Status and Prospect (2011-2021) 1.4.2 France Status and Prospect (2011-2021) 1.4.3 UK Status and Prospect (2011-2021) 1.4.4 Russia Status and Prospect (2011-2021) 1.4.5 Italy Status and Prospect (2011-2021) 1.4.6 Spain Status and Prospect (2011-2021) 1.4.7 Benelux Status and Prospect (2011-2021) 1.5 Europe Market Size (Value and Volume) of Small Animal Imaging Reagents (2011-2021) 1.5.1 Europe Small Animal Imaging Reagents Sales and Growth Rate (2011-2021) 1.5.2 Europe Small Animal Imaging Reagents Revenue and Growth Rate (2011-2021) 10 Europe Small Animal Imaging Reagents Manufacturers Analysis 10.1 Bruker Corporation (U.S.) 10.1.1 Company Basic Information, Manufacturing Base and Competitors 10.1.2 Small Animal Imaging Reagents Product Type, Application and Specification 10.1.2.1 Type I 10.1.2.2 Type II 10.1.3 Bruker Corporation (U.S.) Small Animal Imaging Reagents Sales, Revenue, Price and Gross Margin (2011-2016) 10.1.4 Main Business/Business Overview 10.2 Siemens AG (Germany) 10.2.1 Company Basic Information, Manufacturing Base and Competitors 10.2.2 Small Animal Imaging Reagents Product Type, Application and Specification 10.2.2.1 Type I 10.2.2.2 Type II 10.2.3 Siemens AG (Germany) Small Animal Imaging Reagents Sales, Revenue, Price and Gross Margin (2011-2016) 10.2.4 Main Business/Business Overview 10.3 Life Technologies Corporation (U.S.) 10.3.1 Company Basic Information, Manufacturing Base and Competitors 10.3.2 Small Animal Imaging Reagents Product Type, Application and Specification 10.3.2.1 Type I 10.3.2.2 Type II 10.3.3 Life Technologies Corporation (U.S.) Small Animal Imaging Reagents Sales, Revenue, Price and Gross Margin (2011-2016) 10.3.4 Main Business/Business Overview 10.4 FUJIFILM Holdings Corporation (Japan) 10.4.1 Company Basic Information, Manufacturing Base and Competitors 10.4.2 Small Animal Imaging Reagents Product Type, Application and Specification 10.4.2.1 Type I 10.4.2.2 Type II 10.4.3 FUJIFILM Holdings Corporation (Japan) Small Animal Imaging Reagents Sales, Revenue, Price and Gross Margin (2011-2016) 10.4.4 Main Business/Business Overview 10.5 Miltenyi Biotec GmbH (Germany) 10.5.1 Company Basic Information, Manufacturing Base and Competitors 10.5.2 Small Animal Imaging Reagents Product Type, Application and Specification 10.5.2.1 Type I 10.5.2.2 Type II 10.5.3 Miltenyi Biotec GmbH (Germany) Small Animal Imaging Reagents Sales, Revenue, Price and Gross Margin (2011-2016) 10.5.4 Main Business/Business Overview 10.6 PerkinElmer, Inc. (U.S.) 10.6.1 Company Basic Information, Manufacturing Base and Competitors 10.6.2 Small Animal Imaging Reagents Product Type, Application and Specification 10.6.2.1 Type I 10.6.2.2 Type II 10.6.3 PerkinElmer, Inc. (U.S.) Small Animal Imaging Reagents Sales, Revenue, Price and Gross Margin (2011-2016) 10.6.4 Main Business/Business Overview 10.7 Bioscan, Inc. (U.S.) 10.7.1 Company Basic Information, Manufacturing Base and Competitors 10.7.2 Small Animal Imaging Reagents Product Type, Application and Specification 10.7.2.1 Type I 10.7.2.2 Type II 10.7.3 Bioscan, Inc. (U.S.) Small Animal Imaging Reagents Sales, Revenue, Price and Gross Margin (2011-2016) 10.7.4 Main Business/Business Overview 10.8 Mediso Medical Imaging Systems (Hungary) 10.8.1 Company Basic Information, Manufacturing Base and Competitors 10.8.2 Small Animal Imaging Reagents Product Type, Application and Specification 10.8.2.1 Type I 10.8.2.2 Type II 10.8.3 Mediso Medical Imaging Systems (Hungary) Small Animal Imaging Reagents Sales, Revenue, Price and Gross Margin (2011-2016) 10.8.4 Main Business/Business Overview 10.9 Gamma Medica (U.S.) 10.9.1 Company Basic Information, Manufacturing Base and Competitors 10.9.2 Small Animal Imaging Reagents Product Type, Application and Specification 10.9.2.1 Type I 10.9.2.2 Type II 10.9.3 Gamma Medica (U.S.) Small Animal Imaging Reagents Sales, Revenue, Price and Gross Margin (2011-2016) 10.9.4 Main Business/Business Overview 10.10 Aspect Imaging (Israel) 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Small Animal Imaging Reagents Product Type, Application and Specification 10.10.2.1 Type I 10.10.2.2 Type II 10.10.3 Aspect Imaging (Israel) Small Animal Imaging Reagents Sales, Revenue, Price and Gross Margin (2011-2016) 10.10.4 Main Business/Business Overview Global QYResearch ( http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.


Domonkos B.,Mediso Medical Imaging Systems | Csebfalvi B.,Budapest University of Technology and Economics
VMV 2010 - Vision, Modeling and Visualization | Year: 2010

In this paper, we thoroughly study a trilinear interpolation scheme previously proposed for the Body-Centered Cubic (BCC) lattice. We think that, up to now, this technique has not received the attention that it deserves. By a frequency-domain analysis we show that it can isotropically suppress those aliasing spectra that contribute most to the postaliasing effect. Furthermore, we present an efficient GPU implementation, which requires only six trilinear texture fetches per sample. Overall, we demonstrate that the trilinear interpolation on the BCC lattice is competitive to the linear box-spline interpolation in terms of both efficiency and image quality. As a generalization to higher-order reconstruction, we introduce DC-splines that are constructed by convolving a Discrete filter with a Continuous filter, and easy to adapt to the Face-Centered Cubic (FCC) lattice as well. © The Eurographics Association 2010.


Csebfalvi B.,Budapest University of Technology and Economics | Domonkos B.,Mediso Medical Imaging Systems
Proceedings - SCCG 2010: 26th Spring Conference on Computer Graphics | Year: 2010

Recently, it has been demonstrated that the optimality of the Body-Centered Cubic (BCC) lattice can be utilized also in practice by using either non-separable box-spline filters or tensor-product Bspline filters for reconstructing an originally continuous signal from its discrete BCC-sampled representation. In order to study the frequency-domain behavior of these filters, a 3D analysis of their frequency responses is required. In this paper, we show that direct volume rendering offers a natural tool for such a 3D analysis. As the frequency responses are analytically known, their characteristic isosurfaces can be rendered separately in the pass band and in the stop band. The visualization of the frequency responses conveys information not just on the absolute postaliasing and oversmoothing effects, but also on their direction dependence. In this sense, the frequency-domain behavior of the non-separable box splines and the tensor-product B-splines on the BCC lattice is evaluated for the first time in this paper. Furthermore, we also analyze how the frequency responses are influenced by a discrete prefiltering, which is necessary to fully exploit the approximation power of the higher-order box-spline and B-spline filters. Copyright © 2010 by the Association for Computing Machinery, Inc.


Domonkos B.,Mediso Medical Imaging Systems | Csebfalvi B.,Budapest University of Technology and Economics
Journal of WSCG | Year: 2011

The major preference for applying B-spline filtering rather than non-separable box spline filtering on the BCC lattice is the fact that separable filtering can be performed more efficiently on current GPUs due to the utilization of the hardware-accelerated trilinear texture fetching. In order to make a fair comparison, a similar, efficient evaluation scheme is required that uses trilinear texture fetches instead of nearest-neighbor ones also for the box splines. Thus, in this paper, we propose an evaluation scheme for the linear BCC box spline built upon a trilinear B-spline basis. We compare our trilinearly evaluated linear box spline scheme to the latest method, that uses twice as many nearest neighbor fetches. Then we give a comparison to the major competitive methods: the BCC B-spline filtering and the BCC DC-spline filtering in terms of their performance.


News Article | October 31, 2016
Site: www.newsmaker.com.au

This report studies Nuclear Medicine Equipment in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering  Philips Healthcare  GE Healthcare  Siemens Healthcare  Digirad Corporation  Mediso Medical Imaging Systems  Toshiba Medical Systems  DDD-Diagnostics A/S  Neusoft Medical Systems  SurgicEye  CMR Naviscan Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Nuclear Medicine Equipment in these regions, from 2011 to 2021 (forecast), like  North America  Europe  China  Japan  Southeast Asia  India Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into  hybrid PET  hybrid SPECT  standalone SPECT  planar scintigraphy systems Split by application, this report focuses on consumption, market share and growth rate of Nuclear Medicine Equipment in each application, can be divided into  Cardiology  Oncology  Neurology  Others Global Nuclear Medicine Equipment Market Research Report 2016  1 Nuclear Medicine Equipment Market Overview  1.1 Product Overview and Scope of Nuclear Medicine Equipment  1.2 Nuclear Medicine Equipment Segment by Type  1.2.1 Global Production Market Share of Nuclear Medicine Equipment by Type in 2015  1.2.2 hybrid PET  1.2.3 hybrid SPECT  1.2.4 standalone SPECT  1.2.5 planar scintigraphy systems  1.3 Nuclear Medicine Equipment Segment by Application  1.3.1 Nuclear Medicine Equipment Consumption Market Share by Application in 2015  1.3.2 Cardiology  1.3.3 Oncology  1.3.4 Neurology  1.3.5 Others  1.4 Nuclear Medicine Equipment Market by Region  1.4.1 North America Status and Prospect (2011-2021)  1.4.2 Europe Status and Prospect (2011-2021)  1.4.3 China Status and Prospect (2011-2021)  1.4.4 Japan Status and Prospect (2011-2021)  1.4.5 Southeast Asia Status and Prospect (2011-2021)  1.4.6 India Status and Prospect (2011-2021)  1.5 Global Market Size (Value) of Nuclear Medicine Equipment (2011-2021) 7 Global Nuclear Medicine Equipment Manufacturers Profiles/Analysis  7.1 Philips Healthcare  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors  7.1.2 Nuclear Medicine Equipment Product Type, Application and Specification  7.1.2.1 Type I  7.1.2.2 Type II  7.1.3 Philips Healthcare Nuclear Medicine Equipment Production, Revenue, Price and Gross Margin (2015 and 2016)  7.1.4 Main Business/Business Overview  7.2 GE Healthcare  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors  7.2.2 Nuclear Medicine Equipment Product Type, Application and Specification  7.2.2.1 Type I  7.2.2.2 Type II  7.2.3 GE Healthcare Nuclear Medicine Equipment Production, Revenue, Price and Gross Margin (2015 and 2016)  7.2.4 Main Business/Business Overview  7.3 Siemens Healthcare  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors  7.3.2 Nuclear Medicine Equipment Product Type, Application and Specification  7.3.2.1 Type I  7.3.2.2 Type II  7.3.3 Siemens Healthcare Nuclear Medicine Equipment Production, Revenue, Price and Gross Margin (2015 and 2016)  7.3.4 Main Business/Business Overview  7.4 Digirad Corporation  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors  7.4.2 Nuclear Medicine Equipment Product Type, Application and Specification  7.4.2.1 Type I  7.4.2.2 Type II  7.4.3 Digirad Corporation Nuclear Medicine Equipment Production, Revenue, Price and Gross Margin (2015 and 2016)  7.4.4 Main Business/Business Overview  7.5 Mediso Medical Imaging Systems  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors  7.5.2 Nuclear Medicine Equipment Product Type, Application and Specification  7.5.2.1 Type I  7.5.2.2 Type II  7.5.3 Mediso Medical Imaging Systems Nuclear Medicine Equipment Production, Revenue, Price and Gross Margin (2015 and 2016)  7.5.4 Main Business/Business Overview  7.6 Toshiba Medical Systems  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors  7.6.2 Nuclear Medicine Equipment Product Type, Application and Specification  7.6.2.1 Type I  7.6.2.2 Type II  7.6.3 Toshiba Medical Systems Nuclear Medicine Equipment Production, Revenue, Price and Gross Margin (2015 and 2016)  7.6.4 Main Business/Business Overview  7.7 DDD-Diagnostics A/S  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors  7.7.2 Nuclear Medicine Equipment Product Type, Application and Specification  7.7.2.1 Type I  7.7.2.2 Type II  7.7.3 DDD-Diagnostics A/S Nuclear Medicine Equipment Production, Revenue, Price and Gross Margin (2015 and 2016)  7.7.4 Main Business/Business Overview  7.8 Neusoft Medical Systems  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors  7.8.2 Nuclear Medicine Equipment Product Type, Application and Specification  7.8.2.1 Type I  7.8.2.2 Type II  7.8.3 Neusoft Medical Systems Nuclear Medicine Equipment Production, Revenue, Price and Gross Margin (2015 and 2016)  7.8.4 Main Business/Business Overview  7.9 SurgicEye  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors  7.9.2 Nuclear Medicine Equipment Product Type, Application and Specification  7.9.2.1 Type I  7.9.2.2 Type II  7.9.3 SurgicEye Nuclear Medicine Equipment Production, Revenue, Price and Gross Margin (2015 and 2016)  7.9.4 Main Business/Business Overview  7.10 CMR Naviscan  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors  7.10.2 Nuclear Medicine Equipment Product Type, Application and Specification  7.10.2.1 Type I  7.10.2.2 Type II  7.10.3 CMR Naviscan Nuclear Medicine Equipment Production, Revenue, Price and Gross Margin (2015 and 2016)  7.10.4 Main Business/Business Overview


Pyka T.,TU Munich | Bundschuh R.A.,TU Munich | Bundschuh R.A.,University of Bonn | Andratschke N.,TU Munich | And 6 more authors.
Radiation Oncology | Year: 2015

Background: Textural features in FDG-PET have been shown to provide prognostic information in a variety of tumor entities. Here we evaluate their predictive value for recurrence and prognosis in NSCLC patients receiving primary stereotactic radiation therapy (SBRT). Methods: 45 patients with early stage NSCLC (T1 or T2 tumor, no lymph node or distant metastases) were included in this retrospective study and followed over a median of 21.4months (range 3.1-71.1). All patients were considered non-operable due to concomitant disease and referred to SBRT as the primary treatment modality. Pre-treatment FDG-PET/CT scans were obtained from all patients. SUV and volume-based analysis as well as extraction of textural features based on neighborhood gray-tone difference matrices (NGTDM) and gray-level co-occurence matrices (GLCM) were performed using InterView Fusion™ (Mediso Inc., Budapest). The ability to predict local recurrence (LR), lymph node (LN) and distant metastases (DM) was measured using the receiver operating characteristic (ROC). Univariate and multivariate analysis of overall and disease-specific survival were executed. Results: 7 out of 45 patients (16%) experienced LR, 11 (24%) LN and 11 (24%) DM. ROC revealed a significant correlation of several textural parameters with LR with an AUC value for entropy of 0.872. While there was also a significant correlation of LR with tumor size in the overall cohort, only texture was predictive when examining T1 (tumor diameter < = 3cm) and T2 (>3cm) subgroups. No correlation of the examined PET parameters with LN or DM was shown. Conclusions: Our study adds to the growing evidence that tumor heterogeneity as described by FDG-PET texture is associated with response to radiation therapy in NSCLC. The results may be helpful into identifying patients who might profit from an intensified treatment regime, but need to be verified in a prospective patient cohort before being incorporated into routine clinical practice. © 2015 Pyka et al.; licensee BioMed Central.


Derlin T.,University of Hamburg | Busch J.D.,University of Hamburg | Wisotzki C.,University of Hamburg | Schoennagel B.P.,University of Hamburg | And 4 more authors.
Clinical Nuclear Medicine | Year: 2013

PURPOSE: To determine the diagnostic performance of I- metaiodobenzylguanidine (mIBG) SPECT/MRI fusion, I-mIBG SPECT/CT and adrenal MRI for the detection of pheochromocytoma in patients with elevated urine or plasma catecholamines. PATIENTS AND METHODS: Twenty-two consecutive patients underwent both a whole-body I-mIBG scan with SPECT/CT of the adrenal region and MRI of the adrenal glands. Fused SPECT/MRI, SPECT/CT, and MRI scans were evaluated. Imaging results were analyzed both on a per-patient and on a per-lesion basis. Histopathology and/or clinical and radiological follow-up served as the reference standard. RESULTS: Sixteen adrenal tumors were found in thirteen patients. On a per-lesion basis, SPECT/CT had a sensitivity of 87.5%, a specificity of 93.8%, and an overall accuracy of 92.5%. MRI had a sensitivity of 87.5%, a specificity of 96.9%, and an overall accuracy of 95.0%. On a per-patient basis, both SPECT/CT and MRI had a sensitivity of 85.7%, a specificity of 93.3%, and an overall accuracy of 90.9%. SPECT/CT was concordant with MRI in 81.8% of cases. SPECT/MRI fusion was superior to both SPECT/CT and MRI and had a sensitivity of 100% on both a per-lesion and a per-patient basis. CONCLUSIONS: I-mIBG SPECT/MRI has the highest sensitivity and accuracy for the detection and localization of pheochromocytomas. SPECT/CT and MRI of the adrenal glands are equivalent diagnostic procedures. However, MRI offers the advantage of fully diagnostic assessment of adrenal lesions other than pheochromocytoma undetectable by I-mIBG. Copyright © 2012 by Lippincott Williams & Wilkins.

Loading Mediso Medical Imaging Systems collaborators
Loading Mediso Medical Imaging Systems collaborators